Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | REGN | GSK | ARGX | ||
| Company | Regeneron Pharmaceuticals | Gsk Plc ADR | Argenx Se ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | ||
| Open | 612.07 | 51.79 | 901.11 | ||
| High | 616.24 | 51.94 | 902.89 | ||
| Low | 598.19 | 50.43 | 863.96 | ||
| Latest | 609.94 | 50.67 | 877.72 | ||
| Change | +2.01 | -1.48 | -14.54 | ||
| % Change | +0.33% | -2.84% | -1.63% | ||
| Volume | 2,609,200 | 4,219,300 | 351,900 | ||
| 20-Day Average Volume | 1,207,115 | 3,852,365 | 326,190 | ||
| Previous Close | 607.93 | 52.15 | 892.26 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 618.36 | 51.24 | 853.25 | ||
| 20-Day Raw Stochastic | 31.33% | 43.03% | 71.22% | ||
| 20-Day Relative Strength | 37.66 | 44.84 | 57.66 | ||
| Weighted Alpha | +5.11 | +25.36 | +51.89 | ||
| Today's Opinion | 88% Sell | 8% Sell | 88% Buy | ||
| Previous Opinion | 88% Sell | 8% Buy | 88% Buy | ||
| Last Month's Opinion | 40% Sell | 8% Sell | 24% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.25% since 06/11/26 | -4.14% since 06/11/26 | -2.36% since 06/11/26 | ||
| Low | 598.19 on 06/18/26 | 50.43 on 06/18/26 | 863.96 on 06/18/26 | ||
| High | 620.00 on 06/17/26 | 53.45 on 06/12/26 | 911.88 on 06/12/26 | ||
| 1-Month | |||||
| %Chg | -3.13% since 05/18/26 | +0.82% since 05/18/26 | +13.07% since 05/18/26 | ||
| Low | 591.52 on 06/02/26 | 48.57 on 06/02/26 | 775.62 on 05/19/26 | ||
| High | 651.00 on 05/20/26 | 53.45 on 06/12/26 | 911.88 on 06/12/26 | ||
| 3-Month | |||||
| %Chg | -18.03% since 03/18/26 | -2.67% since 03/18/26 | +28.18% since 03/18/26 | ||
| Low | 591.52 on 06/02/26 | 48.57 on 06/02/26 | 661.85 on 03/20/26 | ||
| High | 781.21 on 04/01/26 | 59.57 on 04/14/26 | 911.88 on 06/12/26 | ||
| 6-Month | |||||
| %Chg | -18.53% since 12/18/25 | +4.93% since 12/18/25 | +3.62% since 12/18/25 | ||
| Low | 591.52 on 06/02/26 | 47.62 on 01/20/26 | 661.85 on 03/20/26 | ||
| High | 821.11 on 01/09/26 | 61.69 on 02/18/26 | 911.88 on 06/12/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 64,482,860 | 102,613,232 | 54,583,640 | ||
| Shares Outstanding, K | 105,720 | 2,025,128 | 62,188 | ||
| Annual Sales | 14,342,900,000 | 43,077,970,000 | 4,248,050,000 | ||
| Annual Net Income | 4,504,900,000 | 7,537,690,000 | 1,292,040,000 | ||
| Last Quarter Sales | 3,605,400,000 | 10,280,080,000 | 1,313,000,000 | ||
| Last Quarter Net Income | 727,200,000 | 2,340,610,000 | 366,000,000 | ||
| 60-Month Beta | 0.25 | 0.36 | 0.47 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 9.47 on 04/29/26 | 1.24 on 04/29/26 | 5.52 on 05/07/26 | ||
| Earnings Date | 08/07/26 | 07/29/26 | 07/30/26 | ||
| Most Recent Dividend | 0.940 on 05/20/26 | 0.454 on 05/15/26 | N/A | ||
| Next Ex-Dividends Date | 05/20/26 | 05/15/26 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 16.36 | 11.26 | 39.73 | ||